MedGenome

MedGenome MedGenome is a global genomics diagnostics company and home to South Asia’s largest CAP-accredited genetic testing lab.

With 1300+ tests across oncology, rare diseases, reproductive health and more, we support accurate diagnosis and better patient care. MedGenome is a global genomics and precision diagnostics company focused on enabling accurate, early and actionable diagnosis through advanced genomic science. We operate South Asia’s largest CAP-accredited genetic testing laboratory and offer a comprehensive test menu of more than 1,300 genetic assays across key disease areas. Our diagnostic capabilities span rare inherited disorders, oncology, reproductive health, infectious diseases and preventive wellness. By integrating next-generation sequencing technologies with proprietary assays and AI-enabled bioinformatics platforms, MedGenome delivers high-quality genomic insights that support clinicians in complex clinical decision-making. Founded with a vision to make genomic healthcare affordable and accessible, MedGenome has built deep scientific and clinical expertise backed by extensive research and global collaborations. Our work is supported by a strong research foundation with hundreds of peer-reviewed scientific publications, reflecting our commitment to evidence-based diagnostics and innovation. MedGenome serves clinicians and healthcare institutions across hundreds of locations in India and multiple countries worldwide. Our team of scientists, genome analysts, bioinformaticians and clinical experts works closely with healthcare providers to ensure test accuracy, clinical relevance and timely reporting. We are driven by a commitment to continuous innovation, quality and education. From developing in-house genomics solutions to advancing awareness around genetic testing, MedGenome plays an active role in shaping the future of precision medicine. At MedGenome, every genome decoded strengthens our mission to improve patient outcomes, support clinicians with reliable insights and transform healthcare through the power of genomics.

Celebrating tradition, togetherness, and festive cheer at MedGenome! 🌼 ...
14/09/2026

Celebrating tradition, togetherness, and festive cheer at MedGenome! 🌼
We welcomed the festive season with joyful Onam & Ganesh Chaturthi celebrations, bringing our teams together for traditional festivities, vibrant floor decorations, delicious snacks, and plenty of happy moments. ✨

It was a beautiful day of celebrating culture, camaraderie, and the spirit of togetherness! 💙

We are honoured to receive the “Excellence in Genomics & Precision Diagnostics” Award at Sanjeevani 2026, organised by t...
12/09/2026

We are honoured to receive the “Excellence in Genomics & Precision Diagnostics” Award at Sanjeevani 2026, organised by the Services Export Promotion Council and supported by the Ministry of Commerce and Industry.

The award recognises our continued commitment to advancing genomics and precision diagnostics across India and enabling better, more informed healthcare outcomes. It is a testament to the dedication of our teams, partners, and the healthcare community in shaping a healthier future.

The award was received by Dr. Avi Nahar on behalf of MedGenome.

We thank the organisers for recognising MedGenome’s contribution to genomics and precision diagnostics. Here’s to pushing the boundaries of precision healthcare and building a stronger, healthier India.

09/09/2026

On 3 September 2026, MedGenome marked a significant milestone in personalised cancer care with the launch of OncoTrack MRD™, an indigenously developed, personalised, ultrasensitive, NGS-based, tumour-informed MRD test.

With a simple blood test, home sample collection, nationwide availability, and affordable pricing, OncoTrack MRD™ testing can be taken multiple times in a year based on clinical requirements making molecular monitoring for cancer relapse convenient and accessible.

This first-of-its-kind genomic innovation in India was unveiled in the presence of leading oncologists Dr. Niti Raizada, Dr. Vinayak Maka, and Dr. Rajeev Vijayakumar, alongside Vedam Ramprasad, PhD, CEO, MedGenome Labs Ltd. The experts came together for an insightful discussion on molecular monitoring playing an integral role in precision oncology.

We extend a heartfelt thank you to our esteemed speakers, media, and everyone who joined us for this momentous occasion. Together, we continue to drive innovation in precision oncology and pave the way for more personalised cancer care in India.

Could there be an early molecular signal of cancer relapse, before it becomes clinically evident?Introducing OncoTrack M...
08/09/2026

Could there be an early molecular signal of cancer relapse, before it becomes clinically evident?

Introducing OncoTrack MRD™ — MedGenome’s personalised, tumor-informed approach to molecular residual disease monitoring in solid tumors.

It starts with a tumor tissue sample to identify patient-specific tumor variants using ultra-sensitive NGS. These variants then serve as a personalised molecular signature for longitudinal monitoring through simple blood samples, collected conveniently from the comfort of home.

Learn more: 🌐 https://tinyurl.com/hamkj7nw | 📞 1800 296 9696

Click here to read the blog: https://tinyurl.com/muntwrdj IVF has come a long way, and genetic testing is helping bring ...
08/09/2026

Click here to read the blog: https://tinyurl.com/muntwrdj

IVF has come a long way, and genetic testing is helping bring greater insight into embryo selection. From understanding chromosomal abnormalities to identifying specific inherited conditions, Preimplantation Genetic Testing (PGT) can support more informed decisions during an IVF journey.

But how does it work, and where does genetic testing fit into IVF care and success rates?

Read our blog to explore the role of PGT-A, PGT-M and PGT-SR, their potential benefits and how genetic insights are shaping modern IVF.

05/09/2026

Introducing MedGenome’s OncoTrack MRD — India’s first tumor-informed, ultra-sensitive ctDNA-based, longitudinal test for molecular residual disease monitoring in solid tumors.

Designed to go beyond what conventional monitoring can reveal, OncoTrack MRD helps answer three critical questions:
🧬 Is there persisting residual disease, even after treatment?
📊 Is the current line of therapy actually working?
⚠️ Is there an early signal of relapse?

To know more about OncoTrack MRD: 🌐https://tinyurl.com/hamkj7nw | 📞1800 296 9696

PGT-A and PGT-M are not interchangeable.While PGT-A screens embryos for chromosomal abnormalities, PGT-M identifies spec...
03/09/2026

PGT-A and PGT-M are not interchangeable.

While PGT-A screens embryos for chromosomal abnormalities, PGT-M identifies specific inherited genetic disorders. Choosing the appropriate test depends on the clinical indication and the question that needs to be answered.

28/08/2026

Misconceptions about genetic testing can delay diagnosis and impact treatment decisions.

In this video, Dr. C.P. Ravi Kumar clears up some common myths and highlights why genetic testing is becoming an important part of personalised healthcare.

“Every day at MedGenome is a chance to learn and grow. I truly appreciate that the company fosters a culture of being pr...
19/08/2026

“Every day at MedGenome is a chance to learn and grow. I truly appreciate that the company fosters a culture of being proactive and innovative, encouraging us to think ahead and bring new ideas to life.
What I value most about working at MedGenome is the real-world impact of the work we do. In the fast-moving field of AI, I’m driven to apply it where it truly matters, solving fundamental problems in genomics and helping deliver better healthcare to patients. What excites me is developing solutions that streamline operations, improve diagnostics, and make the detection of genetic mutations faster, more accurate, and more affordable. Knowing that this work directly contributes to advancing patient care keeps me motivated each day.
By delivering quick and affordable diagnoses for complex diseases through state-of-the-art gene sequencing solutions, MedGenome makes a real difference. Being part of an organization that touches lives in this way gives me the sense that my time and work are meaningfully contributing to society.”
— Aviral Kumar

Three colours. One spirit. A celebration of togetherness.Our teams came together today dressed in the colours of the tri...
15/08/2026

Three colours. One spirit. A celebration of togetherness.

Our teams came together today dressed in the colours of the tricolour, sharing laughter, festive treats and the joy of celebrating India together.

Here’s to the spirit of unity, the strength of our people and the promise of a brighter tomorrow.

Happy Independence Day! 🧡🤍💚

Address

MedGenome Labs Ltd. Sy. Nos. 94/1C And 94/2, Tower 1, Ground Floor, Veerasandra Village, Attibele Hobli, Electronic City Phase-1, Electronics City
Bangalore
560100

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Telephone

+9118001033691

Website

Alerts

Be the first to know and let us send you an email when MedGenome posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MedGenome:

Shortcuts

Share

Category